Nicola Anne Ramsay

Title: Nicola Anne Ramsay: Innovator in Antibody Development

Introduction

Nicola Anne Ramsay is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. With a total of 2 patents, her work focuses on innovative therapeutic solutions.

Latest Patents

Ramsay's latest patents include groundbreaking advancements in anti-TIGIT and anti-CD96 antibodies. The first patent provides multispecific molecules that specifically bind to CD96 and/or TIGIT, along with isolated antibodies that target human TIGIT. This patent also details pharmaceutical compositions that incorporate these molecules and antibodies, as well as methods for treating subjects using these innovative therapies. The second patent focuses on antibodies that specifically bind to human CD96 and antagonize its function. Similar to the first, it includes pharmaceutical compositions, nucleic acids, expression vectors, and methods for treatment.

Career Highlights

Nicola Anne Ramsay is currently employed at Agenus Inc., where she continues to push the boundaries of antibody research. Her work is instrumental in developing new therapeutic options for various diseases, showcasing her commitment to advancing medical science.

Collaborations

Ramsay collaborates with notable colleagues, including Dhan Sidhartha Chand and Olga Ignatovich, who contribute to her research endeavors. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Nicola Anne Ramsay stands out as a key figure in the field of antibody development, with her patents paving the way for new therapeutic strategies. Her contributions are vital to the ongoing advancements in biotechnology and medicine.